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Abstract
We compared the levels of hepatic enzymes in 220 Japanese men with metabolic syndrome
with those in age and sex-matched subjects without the syndrome. Metabolic syndrome was defi
ned by the new criteria published in Japan, and hepatic enzymes, i.e., aspartate aminotransferase
(AST), alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (γGTP), were measured.
AST, ALT and γGTP in subjects with metabolic syndrome were signifi cantly higher than those
in subjects without the syndrome, and metabolic syndrome was closely aociated with hepatic
enzymes in this cohort of Japanese men.
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he metabolic syndrome,  which is characterized 
by abdominal obesity,  dyslipidemia,  and eleva-
tion of blood pressure and fasting plasma glucose lev-
els,  is a common disorder in Japan [1,  2].  For 
example,  in a previous cohort,  30.7ｵ of men and 3.6
ｵ of women were diagnosed as having the metabolic 
syndrome using the new criteria in Japan [1].  The 
metabolic syndrome has been associated with an 
increased risk for cardiovascular disease.  However, 
the link between metabolic syndrome as deﬁ ned using 
the new criteria in Japan and hepatic enzymes still 
remains to be investigated.  In the present study, 
therefore,  we compared the levels of hepatic 
enzymes in subjects with metabolic syndrome with 
those in age and sex-matched subjects without the 
syndrome.
Subjects and Methods
　　Subjects.　 We used the data of 220 Japanese 
men with metabolic syndrome and 263 Japanese men 
without metabolic syndrome,  aged 23ﾝ77 years,  who 
met all of the following criteria : (1) Received an 
annual health checkup each year from June 1997 to 
May 2005 at Okayama Southern Institute of 
Health ; (2) Received fasting blood examination and a 
cardiopulmonary exercise test as part of the annual 
health checkup ; (3) Provided written informed con-
sent ; (4) Had no history of hepatitis virus infection, 
hepatitis B antigen (HBsAg) or antibodies against 
hepatitis C viruses (Table 1).
　　Anthropometric measurements and blood 
examination. Anthropometric parameters,  i.e., 
height,  weight,  and waist circumference,  were mea-
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sured.  Body mass index (BMI) was calculated as 
weight/[height]2 (kg/m2).  The waist circumference 
was measured at the umbilical level.  Blood examina-
tions,  i.e.,  aspartate aminotransferase (AST) by the 
Wroblewski-Karmen method,  alanine aminotransfer-
ase (ALT) by the Wroblewski-Karmen method,  and 
γ-glutamyl transpeptidase (γGTP) by the L-γ-
glutamyl-3-carboxy-4-nitroanilide method,  were also 
measured.  The institutional normal upper limit of 
AST was 35 IU/l,  that of ALT was 35 IU/l,  and 
that of γGTP was 55 IU/l.
　　Diagnosis of metabolic syndrome.　 The 
metabolic syndrome was deﬁ ned,  among men with a 
waist circumference in excess of 85 cm and women 
with a waist circumference in excess of 90 cm,  as 
having 2 or more of following components : 1) 
Dyslipidemia: triglycerides ≧ 150 mg/dl and/or HDL 
cholesterol ＜ 40 mg/dl; 2) High blood pressure:
blood pressure ≧ 130/85 mmHg; 3) Impaired glucose 
tolerance: fasting plasma glucose ≧ 110 mg/dl [2].
32 Acta Med.  Okayama　Vol.  61,  No.  1Miyatake et al.
Table 1　　Comparison of parameters using the criteria and subcriteria of metabolic syndrome in Japanese men
Metabolic syndrome (＋) (－) p Value
Number of Subjects 220 263
Age 48.9±10.5 49.3±11.1 0.6937
Height (cm) 168.6±5.7 168.3±5.7 0.5336
Body weight (kg) 81.4±12.8 71.9±12.1 ＜0.0001
Body mass index (kg/m2) 28.6±3.8 25.3±2.5 ＜0.0001
AST (IU/L) 29.6±12.9 24.7±9.7 ＜0.0001
ALT (IU/L) 43.9±28.3 32.4±22.8 ＜0.0001
γGTP (IU/L) 63.6±51.2 46.2±41.9 ＜0.0001
Waist Circumference (＋) (－)
Number of Subjects 351 132
Age 47.6±10.5 53.1±10.7 ＜0.0001
AST (IU/L) 28.2±11.8 23.5±10.2 ＜0.0001
ALT (IU/L) 42.4±27.7 24.9±15.4 ＜0.0001
γGTP (IU/L) 58.3±47.9 43.1±43.5 0.0015
Dyslipidemia (＋) (－)
Number of Subjects 270 213
Age 49.0±10.8 49.2±10.9 0.8311
AST (IU/L) 29.0±12.8 24.2±9.0 ＜0.0001
ALT (IU/L) 41.9±28.5 32.2±21.5 ＜0.0001
γGTP (IU/L) 61.8±52.3 44.4±37.6 ＜0.0001
High blood pressure (＋) (－)
Number of Subjects 361 122
Age 49.7±10.9 47.5±10.6 0.0528
AST (IU/L) 27.8±12.2 24.2±9.0 0.0031
ALT (IU/L) 38.6±26.6 34.8±24.4 0.1635
γGTP (IU/L) 59.2±50.7 39.3±30.1 ＜0.0001
Impared glucose tolerance (＋) (－)
Number of Subjects 185 298
Age 52.5±9.2 47.0±11.2 ＜0.0001
AST (IU/L) 26.5±13.6 27.2±10.1 0.5213
ALT (IU/L) 37.2±29.6 37.8±23.7 0.7987
γGTP (IU/L) 58.4±54.4 51.5±41.8 0.1222
Metabolic syndrome (Non drinkers) (＋) (－)
Number of Subjects 47 56
Age 46.5±12.0 48.2±12.1 0.4765
AST (IU/L) 32.2±17.3 23.3±9.7 0.0014
ALT (IU/L) 52.7±36.3 32.7±22.2 0.0009
γGTP (IU/L) 47.6±30.9 31.7±21.0 0.0026
2
Acta Medica Okayama, Vol. 61 [2007], Iss. 1, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol61/iss1/4
　　Alcohol consumption habits.　 The data on 
alcohol consumption habits were obtained at inter-
views by well-trained staﬀ  in a structured way.  The 
subjects were asked if they currently drank alcohol 
on a regular basis.  Subjects answering “yes” were 
classiﬁ ed as current drinkers.  Those answering “no” 
were further asked whether they had ever drunk 
alcohol on a regular basis.  Those answering “no” 
were classiﬁ ed as nondrinker and those answering 
“yes” were classiﬁ ed as previous drinkers.
　　Statistical analysis.　 Data are expressed as 
the mean ± standard deviation (SD).  The relationship 
between metabolic syndrome and drinking habits was 
tested using an χ2 test and parameters were com-
pared between groups using an unpaired-t test. 
Values of p ＜ 0.05 were considered to be statistically 
signiﬁ cant.
Results
　　Table 1 and 2 compare the results between sub-
jects with and those without metabolic syndrome. 
There were no signiﬁ cant diﬀ erences in age or drink-
ing habits between the 2 groups.  Body weight and 
BMI in the subjects with metabolic syndrome were 
signiﬁ cantly higher than those in the controls.  The 
levels of AST,  ALT and γGTP were also signiﬁ -
cantly higher in the subjects with metabolic syn-
drome.  We also compared the levels of hepatic 
enzymes between subjects with and without each com-
ponent of the deﬁ nition of metabolic syndrome.  By 
this analysis,  there was no signiﬁ cant diﬀ erence of 
age between subjects with or without dyslipidemia or 
high blood pressure.  However,  there was a signiﬁ -
cant diﬀ erence of age between the sub-groups with or 
without abdominal obesity and impaired glucose tol-
erance.  The levels of AST,  ALT and γGTP in sub-
jects with abdominal obesity or dyslipidemia were 
signiﬁ cantly higher than those in subjects without 
these components of the metabolic syndrome.  AST 
and γGTP in subjects with elevated blood pressure 
were also signiﬁ cantly higher than those in subjects 
with normal blood pressure.
　　To strictly avoid the inﬂ uence of alcohol consump-
tion habits,  we paerformed a separate analysis using 
only data of nondrinkers and compared the hepatic 
enzyme levels between subjects with and those with-
out metabolic syndrome.  As in the overall analsysis, 
the AST,  ALT and γGTP levels in subjects with 
metabolic syndrome were signiﬁ cantly higher than 
those in the subjects without the syndrome.
Discussion
　We compared the hepatic enzyme levels in subjects 
with metabolic syndrome with those in age and sex-
matched controls without metabolic syndrome sub-
jects as deﬁ ned using the criteria in Japan.
　　Nonalcoholic steatohepatitis represents an 
advanced stage of fatty liver disease developed in the 
absence of alcohol abuse and is frequently associated 
with the metabolic syndrome and type 2 diabetes. 
The actual prevalence of nonalcoholic steatohepatitis 
in type 2 diabetes and obesity is unknown.  It is esti-
mated that 75ｵ of type 2 diatetic patients present 
some form of non alcoholic fatty liver of diﬀ erent 
degrees.  Several genetic and acquired factors are 
involved in its pathogenesis [3].  Wannamethee et al. 
reported that elevated levels of ALT and γGTP 
within the normal range are independent predictors 
of type 2 diabetes in older men [4].  Nannipieri et al. 
also reported that mild elevation in hepatic enzymes 
is associated with features of the metabolic syndrome 
by follow-up study [5].
　　The metabolic syndrome is now considered to 
reﬂ ect a failure of normal partitioning of surplus fat 
exclusively into adipose tissue [6,  7].  The failure 
leads to fat storage in the liver,  muscle and pancre-
atic β cells,  which causes hepatic steatosis,  dyslipid-
emia,  hepatic and peripheral insulin resistance,  and 
insulin secretory failure.  Adipocytokines such as 
leptin and adiponectin are proposed to play a critical 
role in preventing accumulation of lipids [7].  In this 
regard,  it is interesting that hypoadiponectinemia 
has been seen in patients with nonalcoholic steato-
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Table 2　　Relationship between metabolic syndrome and 
drinking habits
MS (＋) MS (－)
Current drinker 168 193
Non drinker 47 56
Previous drinker 5 14
Not signiﬁ cant (p＝0.2258) by χ2 test
MS : Metabolic syndrome
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hepatitis [8].  In addition,  administration of adipo-
nectin has been shown to alleviate nonalcoholic fatty 
liver disease in mice [9].  In this study,  hepatic 
enzyme levels in subjects with metabolic syndrome 
were signiﬁ cantly higher than those in subjects with-
out the syndrome,  even after strictly controlling for 
alcohol consumption.  In addition,  a contribution of 
waist circumference and dyslipidemia to the develop-
ment of liver functional abnormality was noted.
　　Potential limitations still remain in our study. 
First,  the cross-sectional study design in our study 
makes it diﬃ  cult to infer causality between metabolic 
syndrome and hepatic enzymes.  Second,  we were not 
able to evaluate hepatic fat accumulation by using 
ultrasound systems.  Therefore,  our ﬁ ndings are not 
fully applicable to clinical and public health practice 
settings.  In conclusion,  metabolic syndrome was 
found to be closely linked to hepatic enzymes in a 
large cohort of Japanese men.  Further intervention 
studies are necessary to test the eﬀ ect of prevention 
and treatment of metabolic syndrome on hepatic 
enzymes.
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